The Deubiquitinating Enzyme Ataxin-3, a Polyglutamine Disease Protein, Edits Lys63 Linkages in Mixed Linkage Ubiquitin ChainsS
Ubiquitin chain complexity in cells is likely regulated by a diverse set of deubiquitinating enzymes (DUBs) with distinct ubiquitin chain preferences. Here we show that the polyglutamine disease protein, ataxin-3, binds and cleaves ubiquitin chains in a manner suggesting that it functions as a mixed...
Saved in:
Published in | The Journal of biological chemistry Vol. 283; no. 39; pp. 26436 - 26443 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
American Society for Biochemistry and Molecular Biology
26.09.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Ubiquitin chain complexity in cells is likely regulated by a diverse set of
deubiquitinating enzymes (DUBs) with distinct ubiquitin chain preferences.
Here we show that the polyglutamine disease protein, ataxin-3, binds and
cleaves ubiquitin chains in a manner suggesting that it functions as a mixed
linkage, chain-editing enzyme. Ataxin-3 cleaves ubiquitin chains through its
amino-terminal Josephin domain and binds ubiquitin chains through a
carboxyl-terminal cluster of ubiquitin interaction motifs neighboring the
pathogenic polyglutamine tract. Ataxin-3 binds both Lys
48
- or
Lys
63
-linked chains yet preferentially cleaves Lys
63
linkages. Ataxin-3 shows even greater activity toward mixed linkage
polyubiquitin, cleaving Lys
63
linkages in chains that contain both
Lys
48
and Lys
63
linkages. The ubiquitin interaction
motifs regulate the specificity of this activity by restricting what can be
cleaved by the protease domain, demonstrating that linkage specificity can be
determined by elements outside the catalytic domain of a DUB. These findings
establish ataxin-3 as a novel DUB that edits topologically complex chains. |
---|---|
Bibliography: | The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3 and Table S1. This work was supported, in whole or in part, by National Institutes of Health Grants NS038712 (to H. L. P.) and AG025688 (to J. P.). This work was also supported by a National Ataxia Foundation grant (to S. M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement”in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. |
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M803692200 |